Journal profile · Respiratory System
Clinical Respiratory Journal
ISSN 1752-6981 · eISSN 1752-699X · Wiley · ENGLAND · Monthly · Founded 2007
Clinical Respiratory Journal: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.99; fully open access; APC about USD 2,430; median 163 days to acceptance (77 articles, last 24 months); community-reported acceptance: fairly easy; 129 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical Respiratory Journal is published by Wiley and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases and Lung Cancer Diagnosis and Treatment, together about 32% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The Clinical Respiratory Journal (CRJ) provides a forum for clinical research in all areas of respiratory medicine from clinical lung disease to basic research relevant to the clinic. We publish original research, review articles, case studies, editorials and book reviews in all areas of clinical lung disease including: Asthma; Allergy; COPD; Non-invasive ventilation; Sleep-related breathing disorders; Interstitial lung diseases; Lung cancer; Clinical genetics; Rhinitis; Airway and lung infection; Epidemiology; Pediatrics. The Clinical Respiratory Journal provides a fast-track service for selected Phase II and Phase III trial studies.
From the journal's Aims & Scope
Research area (LetPub): Respiratory System
Editor-in-chief Yuanlin SongPublisher website
Editorial board by country: 27 in mainland China (about 87%); most named Mainland China 27, United Kingdom 1, South Korea 1, Italy 1, Greece 1 (31 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine16.3%
- Asthma and respiratory diseasesMedicine9.6%
- Lung Cancer Diagnosis and TreatmentMedicine6.1%
- Respiratory Support and MechanismsMedicine6%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine6%
- Respiratory and Cough-Related ResearchMedicine4.9%
- Tracheal and airway disordersMedicine4.3%
- Delphi Technique in ResearchSocial Sciences3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPMCEmbasePublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.99LetPub ·
- Impact factor (publisher)
- 2.2Publisher website ·
- Impact factor (publisher) 2025
- 2.2Publisher website ·
- CiteScore 2026-06
- 4.2LetPub ·
- CiteScore (publisher)
- 4.2Publisher website ·
- CiteScore (publisher) 2025
- 4.2Publisher website ·
- SJR 2026-06
- 0.66LetPub ·
- SNIP 2026-06
- 0.87LetPub ·
- h-index
- 27LetPub ·
- h-index
- 63OpenAlex ·
- i10-index
- 978OpenAlex ·
- 2-year mean citedness
- 1.97OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 97LetPub ·
- Articles per year (publisher)
- 2Publisher website ·
- Articles per year (publisher) 2025
- 100Publisher website ·
- Downloads per year (publisher) 2025
- 357,321Publisher website ·
Articles by year OpenAlex count · 2,418 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 87 | 87 | 22 |
| 2025 | 129 | 129 | 185 |
| 2024 | 154 | 154 | 521 |
| 2023 | 166 | 166 | 1,144 |
| 2022 | 121 | 121 | 1,487 |
| 2021 | 151 | 53 | 1,216 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
163 daysMedian, submission to acceptance · P25–P75 101 days – 328 days
- Acceptance to online
- median 17 days (77 articles)
- Submission to online
- median 184 days
- Sample
- 77 articles with submission and acceptance dates (226 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 12%Publisher website ·
- Acceptance rate (publisher) 2025
- 12%Publisher website ·
- Submission to first decision
- 40 daysPublisher website ·
- Submission to first decision 2025
- 40 daysPublisher website ·
- Submission to acceptance 2025
- 215 daysPublisher website ·
- Acceptance to publication 2025
- 19 daysPublisher website ·
- Submission to publication (journal-reported)
- about 35 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,430 / GBP 1,800 / EUR 2,070 | Yes | CC BY | |
| OpenAlex | USD 2,310 / EUR 1,970 / GBP 1,800 | — | — | |
| LetPub | EUR 1,700 / GBP 1,550 / USD 2,000 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- First submission
- Free format: the journal's layout is not required
Article types accepted18, with length limits
- book reviewBook Reviews of 700 maximum words are welcome.Length not stated
- book reviewsPublishing original research, review articles, case studies, editorials and book reviews in all areas of clinical lung disease.Length not stated
- brief reportviews of 700 maximum words are welcome. Brief Report Word limit: 1,200 words maximum including abstract but excluding references, tablesmain text ≤ 1,200 words
- case studiesPublishing original research, review articles, case studies, editorials and book reviews in all areas of clinical lung disease.Length not stated
- commentary00 words and no more than 3 references. Commentary Word limit: 1,500 words maximum excluding references. Abstract: not required. Refermain text ≤ 1,500 words
- editorialManuscripts will be single-blind peer-reviewed. At the discretion of the Editor-in-Chief, the submitted manuscript may be rejected immediately, without full rev…main text ≤ 700 words · references ≤ 3
- editorialsPublishing original research, review articles, case studies, editorials and book reviews in all areas of clinical lung disease.Length not stated
- forumForum Word limit: 500 words maximum. Abstract: Not required.Length not stated
- letter to the editorWord limit: 700 words maximum.Abstract: Not required.References: 10 maximum.main text ≤ 700 words
- letter to the editor/replyLetter to the Editor/Reply Word limit: 700 words maximum. Abstract: Not required. References: 10 maximum.Length not stated
- mini reviewles: 1 maximum. Keywords: Not required. Mini Review Word limit: 3,000 words maximum including abstract but excluding references, tablesmain text ≤ 3,000 words · abstract ≤ 250 words
- original articleMANUSCRIPT CATEGORIES AND REQUIREMENTS Original Article Word limit: 5,000 words maximum including abstract but excluding references, tablesmain text ≤ 5,000 words · abstract ≤ 250 words
- original researchPublishing original research, review articles, case studies, editorials and book reviews in all areas of clinical lung disease.Length not stated
- perspectivecribe recent developments in the field. Perspective Word limit: 1,500 words. Abstract: 150 words, unstructured. References: 10 maximum.main text ≤ 1,500 words
- profileProfile Description: Interviews or introductions of top-tier scientists in the field of respiratory medicine. Word limit: 1200 words maximum. Abstract: Not requ…Length not stated
- protocollly not entertained unless exceptional. Protocol Word limit: 3,000 words maximum (main text only). Abstract: 250 words, structured wmain text ≤ 3,000 words · abstract ≤ 250 words
- review articlein the text, as supplementary material. Review Article Word limit: 8,000 words maximum, excluding references, tables and figures. Abstractmain text ≤ 8,000 words · abstract ≤ 250 words
- review articlesPublishing original research, review articles, case studies, editorials and book reviews in all areas of clinical lung disease.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, Open access, Peer review
- Authorship Authorship Statement
Please list a description of each author’s contribution or role, e.g. “designed research/study”, “performed research/study”, “contributed important reagents”, “collected data”, “analyzed data”, “wrote the paper” etc. On initial submission, the submitting author will be prompted to provide the email address and country of all contributing authors.
Source ↗Publisher website ·- Conflicts of interest Disclosure Statement
The Disclosure must declare any financial support or relationships that may pose a conflict of interest. This includes any financial arrangements authors have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. To prevent ambiguity, all authors must state explicitly whether potential conflicts do or do not exist. This informati…
Source ↗Publisher website ·- Data availability Data Sharing and Data Availability
Data sharing expected Model summary
The journal expects authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement in the manuscript, including a link to the repository they have used, in order that this statement can be published alongside their paper. Review Wiley’s Data Sharing policy and Wiley’s Data …
Source ↗Publisher website ·- Publication ethics Publication Ethics
COPE member Model summary
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). This journal follows the core practices of the Committee on Publication Ethics (COPE) and handles cases of research and publication misconduct accordingly (https://publicationethics.org/core-practices). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlappi…
Source ↗Publisher website ·- Open access Open Access
The Clinical Respiratory Journal (CRJ) is an open access journal providing a forum for clinical research in all areas of respiratory medicine from clinical lung disease to basic research relevant to the clinic. Model summary
The Clinical Respiratory Journal has joined Wiley’s Open Access portfolio as of January 2022. As a result, all submissions received from 8 December 2021 are subject to an Article Publication Charge if accepted and published in the journal (unless a waiver is applied). The journal does not charge any submission fees. For more information on the fees, please click here.
Source ↗Publisher website ·- Peer review
Single-blind peer review Model summary
Manuscripts will be single-blind peer-reviewed.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 2007
- ISSN
- 1752-6981
- Electronic ISSN
- 1752-699X
- Latest issue on the website
- Volume 20, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Clinical Respiratory Journal
What CAS zone is Clinical Respiratory Journal in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Respiratory Journal is in Zone 4 of Medicine, and in Zone 4 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Respiratory Journal?
The latest impact factor listed by LetPub is 1.99; CiteScore 4.2, h-index 63.
How long does peer review take at Clinical Respiratory Journal?
Based on the dates recorded on 77 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 163 days (interquartile range 101–328 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 12% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Clinical Respiratory Journal based?
Of the 31 board members whose country the journal's board page names, 27 (about 87%) are in mainland China; the countries named most often are Mainland China (27), United Kingdom (1) and South Korea (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical Respiratory Journal?
According to LetPub and DOAJ records, Clinical Respiratory Journal is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, PMC and Embase; that list has not been checked against each database.
Is Clinical Respiratory Journal open access, and what is the APC?
Clinical Respiratory Journal is a fully open-access journal. APC about USD 2,430.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .